Power3 Medical Products, Inc., a bio-technology company, focuses on the development of diagnostic tests in the fields of cancer, and neurodegenerative, and neuromuscular diseases in the United States. The company develops a portfolio of products, including BC-SeraPro, a blood serum test for the early detection of breast cancer; and NuroPro, a blood serum test for the detection of neurodegenerative diseases, such as amytrophic lateral sclerosis, Alzheimer’s, and Parkinson’s diseases. Its products are designed to analyze proteins and their mutations to assess an individual’s risk for developing disease later in life or a patient’s likelihood of responding to a particular drug; assess a patient’s risk of disease progression and disease recurrence; and measure a patient’s exposure to drug therapy. The company was formerly known as Surgical Safety Products, Inc. and changed its name to Power3 Medical Products, Inc. in September 2003. Power3 Medical Products, Inc. was founded in 1992 and is headquartered in The Woodlands, Texas.